SHANGHAI,
Dec. 7, 2015
/PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc.
(NYSE: WX), a leading open-access R&D capability and
technology platform company serving the pharmaceutical,
biotechnology, and medical device industries, today announced that
Dr. Ge Li, WuXi's Chairman and CEO,
was named Executive of the Year at the 11th annual SCRIP Awards on
December 2 in London.
Established by SCRIP Intelligence, a leading industry news and
strategic analysis firm covering the global pharmaceutical and
biotech industry, the annual SCRIP Awards recognize the industry's
highest achievements by both companies and individuals across the
value chain.
Dr. Li was recognized for his vision in building an
open-access R&D capability and technology platform to help
advance innovative medicines more efficiently and cost effectively.
Under his exemplary leadership, WuXi platform is enabling the
efforts of more than 2,000 collaborative partners worldwide and
contributing to breakthrough therapies that are profoundly
improving patients' lives.
"I am deeply honored and inspired by this award," said Dr.
Li. "I would like to thank our many customers and partners
for their tremendous support for our efforts. It has been our
great privilege to help bring some of the most innovative
healthcare products closer to patients."
About WuXi PharmaTech
WuXi PharmaTech is a leading open-access R&D
capability and technology platform company serving the
pharmaceutical, biotechnology, and medical device industries, with
operations in China and the United
States. As a research-driven and customer-focused company,
WuXi PharmaTech provides a broad and integrated portfolio of
services throughout the drug and medical device R&D
process. WuXi is also building a platform to provide clinical
diagnostic services directly to physicians and their patients
globally. WuXi PharmaTech's services are designed to assist
its global partners in shortening the cycle and lowering the cost
of drug and medical device R&D. WuXi PharmaTech's operating
subsidiaries are known as WuXi AppTec. For more information,
please visit http://www.wuxiapptec.com.
For more information, please contact:
Ronald Aldridge (for
investors)
LaVoieHealthScience
+1 617-374-8800 x109
+1
617-792-2459
ron_aldridge@wuxiapptec.com
Aaron Shi (for media)
Director, Corporate Communications
WuXi
PharmaTech
+86-21-5046-4362
aaron_shi@wuxiapptec.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dr-ge-li-receives-executive-of-the-year-award-from-scrip-300188585.html
SOURCE WuXi PharmaTech (Cayman) Inc.